These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35499710)

  • 81. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.
    Huang ZH; Li LH; Yang F; Wang JF
    World J Gastroenterol; 2007 Feb; 13(6):950-4. PubMed ID: 17352030
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Methylation epigenotypes and genetic features in colorectal laterally spreading tumors.
    Sakai E; Ohata K; Chiba H; Matsuhashi N; Doi N; Fukushima J; Endo H; Takahashi H; Tsuji S; Yagi K; Matsusaka K; Aburatani H; Nakajima A; Kaneda A
    Int J Cancer; 2014 Oct; 135(7):1586-95. PubMed ID: 24590867
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Variation risks of SFRP2 hypermethylation between precancerous disease and colorectal cancer.
    Sui C; Wang G; Chen Q; Ma J
    Tumour Biol; 2014 Oct; 35(10):10457-65. PubMed ID: 25053594
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Diagnostic Strategies toward Clinical Implementation of Liquid Biopsy RAS/BRAF Circulating Tumor DNA Analyses in Patients with Metastatic Colorectal Cancer.
    van 't Erve I; Greuter MJE; Bolhuis K; Vessies DCL; Leal A; Vink GR; van den Broek D; Velculescu VE; Punt CJA; Meijer GA; Coupé VMH; Fijneman RJA
    J Mol Diagn; 2020 Dec; 22(12):1430-1437. PubMed ID: 32961317
    [TBL] [Abstract][Full Text] [Related]  

  • 86. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
    de Vogel S; Weijenberg MP; Herman JG; Wouters KA; de Goeij AF; van den Brandt PA; de Bruïne AP; van Engeland M
    Ann Oncol; 2009 Jul; 20(7):1216-22. PubMed ID: 19164452
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions.
    Li Y; Li B; Jiang R; Liao L; Zheng C; Yuan J; Zeng L; Hu K; Zhang Y; Mei W; Hong Z; Xiao B; Kong L; Han K; Tang J; Jiang W; Pan Z; Zhang S; Ding P
    Cancer Med; 2023 Nov; 12(21):20626-20638. PubMed ID: 37881109
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparison of Performance of Two Stool DNA Tests and a Fecal Immunochemical Test in Detecting Colorectal Neoplasm: A Multicenter Diagnostic Study.
    Jin P; You P; Fang J; Kang Q; Gu F; Cai Y; Zhai H; Wang B; Li Y; Xu J; Wang J; He Y; Wang Y; Dai M; Sheng J
    Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):654-661. PubMed ID: 34933958
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.
    Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M
    J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A panel of genes methylated with high frequency in colorectal cancer.
    Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL
    BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Validation of methylation-sensitive high-resolution melting (MS-HRM) for the detection of stool DNA methylation in colorectal neoplasms.
    Xiao Z; Li B; Wang G; Zhu W; Wang Z; Lin J; Xu A; Wang X
    Clin Chim Acta; 2014 Apr; 431():154-63. PubMed ID: 24518356
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Performance evaluation of stool DNA methylation tests in colorectal cancer screening: a systematic review and meta-analysis.
    Gachabayov M; Lebovics E; Rojas A; Felsenreich DM; Latifi R; Bergamaschi R
    Colorectal Dis; 2021 May; 23(5):1030-1042. PubMed ID: 33410272
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.
    Bosch LJ; Mongera S; Terhaar Sive Droste JS; Oort FA; van Turenhout ST; Penning MT; Louwagie J; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
    Cell Oncol (Dordr); 2012 Aug; 35(4):309-15. PubMed ID: 22821210
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparison of Biocartis IDYLLA ™ cartridge assay with Qiagen GeneReader NGS for detection of targetable mutations in EGFR, KRAS/NRAS, and BRAF genes.
    Haiduk T; Brockmann M; Tillmann RL; Pieper M; Lüsebrink J; Schildgen V; Schildgen O
    Exp Mol Pathol; 2021 Jun; 120():104634. PubMed ID: 33773991
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
    Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
    Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
    Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
    Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Circulating tumor DNA-based early detection of precancerous colorectal lesions using QClamp XNA-mediated real-time PCR.
    Chen S; Wang Y; Wang K; Zhang L; Zhang X
    Pharmazie; 2021 Dec; 76(12):606-610. PubMed ID: 34986957
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer.
    Tang D; Liu J; Wang DR; Yu HF; Li YK; Zhang JQ
    Clin Invest Med; 2011 Apr; 34(2):E88-95. PubMed ID: 21463549
    [TBL] [Abstract][Full Text] [Related]  

  • 99. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
    Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS
    PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Methylation of Septin9, SRSF1, and PAX8 in Early Screening of Colorectal Cancer in the Population Undergoing Physical Examinations.
    Li Q; Jiang W; Zhang Y; Yang X; Huang T; Huang Y; Yang S; Wang Q
    Clin Lab; 2023 Dec; 69(12):. PubMed ID: 38084698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.